JPMorgan China Growth & Income plc

JPMorgan China Growth & Income plc is a UK-domiciled investment trust, established on October 1, 1993. This closed-ended equity fund is managed by JPMorgan Funds Limited, with support from co-manager JPMorgan Asset Management (UK) Limited. Its primary objective is to invest in public stock markets across the Greater China region, concentrating mainly on growth-oriented companies operating in diverse industries. The fund constructs its portfolio using comprehensive fundamental analysis, carefully evaluating factors such as the clarity of earnings and cash flow, the strength of balance sheets, and brand equity. Its investment performance is benchmarked against the MSCI Golden Dragon Index.

JPMorgan China Growth & Income plc trades as JCGI.L on LSE. The company is classified in Financial Services / Asset Management - Income and reports in GBP.

The current profile places the business in Asset Management - Income. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £11.44M of revenue and £63.47M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

JPMorgan China Growth & Income plc can be compared against peers such as B.P. Marsh & Partners PLC, Brooks Macdonald Group plc, Castelnau Group Limited, CQS Natural Resources Growth and Income plc, Impax Asset Management Group plc, JPMorgan Asia Growth & Income plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £222.14M, beta of 0.84, and return on equity of +22.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

JCGI.L currently shows total debt of £0 and beta of 0.84. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://am.jpmorgan.co.uk/investment-trusts/trusts/chinese-jpm-it.aspx?isin=GB0003435012

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.